Impact of response to thalidomide-, lenalidomide- or bortezomib-containing induction therapy on the outcomes of multiple myeloma patients undergoing autologous transplantation

被引：5
|
作者：
Awan, F. T. [1 ]
Osman, S. [2 ]
Kochuparambil, S. T. [1 ]
Gibson, L. [2 ]
Remick, S. C. [2 ]
Abraham, J. [2 ]
Craig, M. [2 ]
Jillella, A. [1 ]
Hamadani, M. [2 ]
机构：
[1] Med Coll Georgia, Dept Internal Med, Div Hematol Oncol, Augusta, GA 30912 USA
[2] W Virginia Univ, MBRCC, Osborn Hematopoiet Malignancy & Transplantat Prog, Morgantown, WV 26506 USA
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷 / 01期
关键词：
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; HIGH-DOSE MELPHALAN; AUTOTRANSPLANTATION; CHEMOTHERAPY; TRIAL;
D O I：
10.1038/bmt.2011.18
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：146 / 148
页数：3
相关论文
共 50 条
  • [31] Outcomes of Patients with Multiple Myeloma Who Received VRD Induction, Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance
    Gaballa, Mahmoud R.
    Al-Juhaishi, Taha
    Bashir, Qaiser
    Srour, Samer A.
    Saini, Neeraj
    Ramdial, Jeremy
    Nieto, Yago
    Murphy, Regan
    Lee, Hans C.
    Patel, Krina K.
    Kebriaei, Partow
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BLOOD, 2020, 136
  • [32] Retrospective Comparison of Bortezomib-containing Regimens with Vincristine-Doxorubicin-Dexamethasone (VAD) as Induction Treatment Prior to Autologous Stem Cell Transplantation for Multiple Myeloma
    Eom, Hyeon-Seok
    Min, Chang-Ki
    Cho, Byung-Sik
    Lee, Seok
    Lee, Jong-Wook
    Min, Woo-Sung
    Kim, Chun-Choo
    Kim, Myungshin
    Kim, Yonggoo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (07) : 449 - 455
  • [33] The Efficacy and Safety of Bortezomib and Dexamethasone as a Maintenance Therapy in Patients With Advanced Multiple Myeloma Who Are Responsive to Salvage Bortezomib-Containing Regimens
    Benevolo, Giulia
    Larocca, Alessandra
    Gentile, Massimo
    Pregno, Patrizia
    Gay, Francesca
    Botto, Barbara
    Frairia, Chiara
    Evangelista, Andrea
    Morabito, Fortunato
    Boccadoro, Mario
    Vitolo, Umberto
    Palumbo, Antonio
    CANCER, 2011, 117 (09) : 1884 - 1890
  • [34] Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma
    M Cavo
    L Pantani
    A Pezzi
    M T Petrucci
    F Patriarca
    F Di Raimondo
    G Marzocchi
    M Galli
    V Montefusco
    E Zamagni
    B Gamberi
    P Tacchetti
    A Brioli
    A Palumbo
    P Sonneveld
    Leukemia, 2015, 29 : 2429 - 2431
  • [35] Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma
    Cavo, M.
    Pantani, L.
    Pezzi, A.
    Petrucci, M. T.
    Patriarca, F.
    Di Raimondo, F.
    Marzocchi, G.
    Galli, M.
    Montefusco, V.
    Zamagni, E.
    Gamberi, B.
    Tacchetti, P.
    Brioli, A.
    Palumbo, A.
    Sonneveld, P.
    LEUKEMIA, 2015, 29 (12) : 2429 - 2431
  • [36] The impact of race on outcomes of autologous transplantation in patients with multiple myeloma
    Verma, Pramvir S.
    Howard, Robin S.
    Weiss, Brendan M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (05) : 355 - 358
  • [37] COMPARISON OF BORTEZOMIB AND LENALIDOMIDE BASED REGIMENS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA PATIENTS
    Malkan, U.
    Gunes, G.
    Yayar, O.
    Can, E. Saribacak
    Okay, M.
    Goker, H.
    LEUKEMIA RESEARCH, 2017, 61 : S22 - S23
  • [38] Early versus delayed autologous stem cell transplantation for multiple myeloma in patients receiving induction therapy with bortezomib
    Osipov, I.
    Darskaya, E.
    Babenko, E.
    Vavilov, V.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5626 - 5626
  • [39] Sequential Bortezomib, Dexamethasone, and Thalidomide Maintenance Therapy after Single Autologous Peripheral Stem Cell Transplantation in Patients with Multiple Myeloma
    Sahebi, Firoozeh
    Frankel, Paul H.
    Farol, Len
    Krishnan, Amrita Y.
    Cai, Ji-lian
    Somlo, George
    Thomas, Sandra H.
    Reburiano, Eunicia
    Popplewell, Leslie L.
    Parker, Pablo M.
    Spielberger, Ricardo T.
    Karanes, Chatchada
    Htut, Myo
    Ruel, Christopher
    Duarte, Lupe
    Murata-Collins, Joyce L.
    Forman, Stephen J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (03) : 486 - 492
  • [40] The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation
    Shimazu, Yutaka
    Kanda, Junya
    Suzuki, Kazuhito
    Wada, Akinori
    Kikuchi, Taku
    Ikeda, Takashi
    Tsukada, Nobuhiro
    Miwa, Akiyoshi
    Itagaki, Mitsuhiro
    Kako, Shinichi
    Nishiwaki, Kaichi
    Ota, Shuichi
    Fujiwara, Shin-ichiro
    Kataoka, Keisuke
    Doki, Noriko
    Sawa, Masashi
    Hiramoto, Nobuhiro
    Nishikawa, Akinori
    Imai, Toshi
    Ichinohe, Tatsuo
    Kanda, Yoshinobu
    Atsuta, Yoshiko
    Kawamura, Koji
    CANCER SCIENCE, 2024, 115 (07) : 2384 - 2395
12345